Kalaris Therapeutics, Inc.
KLRS
$4.90
-$0.32-6.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 117.98M | 77.00M | 88.43M | 100.97M | 1.64M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 827.00K | 1.18M | 3.23M | 1.22M | 967.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 118.81M | 78.18M | 91.65M | 102.18M | 2.61M |
|
|
|||||
| Total Current Assets | 118.81M | 78.18M | 91.65M | 102.18M | 2.61M |
| Net Property, Plant & Equipment | 1.48M | 1.52M | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.45M | 1.48M | 1.19M | 910.00K | 3.56M |
| Total Assets | 121.74M | 81.18M | 92.84M | 103.09M | 6.16M |
|
|
|||||
| Total Accounts Payable | 1.28M | 494.00K | 3.68M | 2.37M | 1.56M |
| Total Accrued Expenses | 8.12M | 5.20M | 3.83M | 4.54M | 2.15M |
| Short-term Debt | -- | -- | -- | -- | 19.91M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 316.00K | 376.00K | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 142.00K | 230.00K | 1.09M |
| Total Other Current Liabilities | -- | -- | 142.00K | 230.00K | 1.09M |
| Total Current Liabilities | 9.71M | 6.07M | 7.65M | 7.14M | 24.70M |
|
|
|||||
| Total Current Liabilities | 9.71M | 6.07M | 7.65M | 7.14M | 24.70M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 19.91M |
| Capital Leases | 1.13M | 1.17M | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 32.08M | 32.08M | 32.08M | 32.08M | 32.08M |
| Total Liabilities | 42.92M | 39.31M | 39.73M | 39.22M | 56.78M |
|
|
|||||
| Common Stock & APIC | 238.81M | 191.86M | 191.22M | 190.63M | 19.95M |
| Retained Earnings | -160.00M | -150.00M | -138.11M | -126.76M | -116.56M |
| Treasury Stock & Other | 6.00K | 6.00K | -- | -- | -- |
| Total Common Equity | 78.81M | 41.87M | 53.12M | 63.87M | -96.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 46.00M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 46.00M |
|
|
|||||
| Total Common Equity | 78.81M | 41.87M | 53.12M | 63.87M | -96.62M |
| Total Preferred Equity | -- | -- | -- | -- | 46.00M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 78.81M | 41.87M | 53.12M | 63.87M | -50.62M |
|
|
|||||